Original Article
The Severe Respiratory Insufficiency Questionnaire was valid for COPD patients with severe chronic respiratory failure

https://doi.org/10.1016/j.jclinepi.2007.09.009Get rights and content

Abstract

Objectives

The Severe Respiratory Insufficiency (SRI) Questionnaire has recently been developed and validated for the assessment of health-related quality of life (HRQL) in patients with severe chronic respiratory failure resulting from a broad spectrum of underlying disorders. The present study was aimed at reexamining the internal structure of the SRI specifically for chronic obstructive pulmonary disease (COPD) patients.

Study Design and Setting

Cross-validation was performed in two COPD groups (N = 78 and N = 84), each receiving home mechanical ventilation in addition to long-term oxygen therapy. The internal consistency reliability was calculated using Cronbach's α coefficient. Explorative Factor Analysis was performed followed by Confirmatory Factor Analysis to establish construct validity.

Results

In the total group (N = 162) Cronbach's α ranged from 0.73 to 0.88. Only one factor could be established which explained 58.5% of the total variance confirming one Summary Scale (SRI-SS). For each of the seven subscales, Confirmatory Factor Analysis revealed two factors, which were substantially correlated (r = 0.43–0.80). All scale scores covered a broad range of the questionnaire's scaling range (0–100). The mean SRI-SS score was 52 ± 17 indicating a homogenous scaling distribution.

Conclusion

The SRI is a multidimensional and highly specific tool with high psychometric properties for HRQL assessment in COPD patients with severe chronic respiratory failure.

Introduction

The evaluation of health-related quality of life (HRQL) in patients with chronic and noncurable disorders is becoming more essential in health care practice and research because it provides an important means of evaluating the human and financial costs and benefits of modern medical treatment modalities [1], [2], [3]. In clinical studies, questionnaires are the most frequently used tool for the assessment of HRQL; here, disease-specific questionnaires are postulated to be more sensitive than generic questionnaires to changes and, therefore, to be most appropriate for clinical trials in which specific therapeutic interventions are being evaluated [1].

Noninvasive positive pressure ventilation (NPPV) has been increasingly used to treat hypercapnic chronic respiratory failure (CRF) that can arise from various underlying disorders such as chest wall deformities, neuromuscular disorders, obesity hypoventilation syndrome, or chronic obstructive pulmonary disease (COPD) [4], [5]. Healing is not possible in the vast majority of CRF patients who receive life-long NPPV as a means of home mechanical ventilation (HMV). Therefore, the assessment of HRQL is extremely important in these severely ill patients.

There is overwhelming evidence to suggest that physiological parameters such as blood gases, survival, and even HRQL increase in patients with chest wall deformities or neuromuscular disorders after the implementation of HMV [6], [7], [8], [9], [10]. In contrast, there are conflicting data about patients with COPD [11], [12], [13], and the survival benefits of adding HMV to long-term oxygen therapy (LTOT) have not yet been documented [14], [15]. In addition, longitudinal studies have indicated only minor and inconsistent changes of HRQL after NPPV in stable hypercapnic COPD [15], [16], [17], [18], [19]. Although this might be due to selection bias, failing effectiveness of HMV or differences in sample size in different studies, inconsistent results might also be confounded by the different methodologies used to assess HRQL.

Well-validated health measures that specifically address HRQL in patients with severe CRF and primarily focus on COPD patients do not exist. Accordingly, if inappropriate measures are used, all conclusions regarding the impact of HMV on HRQL must be deemed premature. This calls for more appropriate studies on HRQL that are specifically tailored to better indicate the role of NPPV in patients with stable hypercapnic COPD. Recently, we developed the Severe Respiratory Insufficiency Questionnaire (SRI), which was shown to be appropriate for clinical trials aimed at assessing HRQL in CRF patients receiving HMV treatment [20]. However, the SRI has been validated for a broad spectrum of patients with CRF rather than specifically for COPD. Therefore, the aim of the present study was to reexamine the internal structure of the SRI for patients with CRF that was induced exclusively by COPD, thus providing a suitable instrument that reliably allows the longitudinal assessment of HRQL in these patients.

Section snippets

Methods

The study protocol was approved by the institutional review board for human studies of the University of Regensburg, Germany, and was performed in accordance with the ethical standards laid down in the 2000 Declaration of Helsinki. Informed written consent was obtained from all subjects.

Results

Demographic data and lung function parameters are illustrated in Table 1. All patients had severe airflow obstruction, although this tended to be more evident in patients of Group 1. These patients were also younger, but body mass index was similar compared to Group 2.

The SRI Questionnaire

The present study indicates that the SRI is a valuable tool for the assessment of specific aspects of HRQL in patients with COPD and CRF. High psychometric properties have been demonstrated by this validation study, which covers a total number of 162 patients, all with severe CRF. Two different groups of patients with somewhat different age distribution and airflow obstruction have been studied. Therefore, psychometric properties have been provided for a broad range of COPD patients with CRF.

References (29)

  • M.A. Testa et al.

    Assessment of quality-of-life outcomes

    N Engl J Med

    (1996)
  • I.J. Higginson et al.

    Measuring quality of life: using quality of life measures in the clinical setting

    BMJ

    (2001)
  • S. Mehta et al.

    Noninvasive ventilation

    Am J Respir Crit Care Med

    (2001)
  • S.J. Lloyd-Owen et al.

    Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey

    Eur Respir J

    (2005)
  • Cited by (62)

    • Health-related quality of life measurement in patients with chronic respiratory failure

      2018, Respiratory Investigation
      Citation Excerpt :

      While the MRF is valid in patients using NIV and/or LTOT, the MRF-28 was first validated for COPD or kyphoscoliosis [6], and its validation for other disorders is limited. On the other hand, the SRI has been more widely validated for various disorders such as COPD, restrictive thoracic disorders, neuromuscular disorders, and obesity hypoventilation syndrome (OHS), among others [7,10]. The minimal clinically important differences for the MRF and SRI have yet to be determined.

    • Validation of the portuguese severe respiratory insufficiency questionnaire for home mechanically ventilated patients

      2017, Revista Portuguesa de Pneumologia (English Edition)
      Citation Excerpt :

      In our study, we think patients might have considered that these 2 components do not necessarily measure the same concept and, thus, the low internal consistency of this subscale. As in previous studies, we found in our factor analysis, that more subscales in addition to the original seven could theoretically have been incorporated and this relates to the complexity of HRQL measuring in respiratory patients.4,5,17 This study found that HRQL is significantly impaired in home mechanically ventilated patients.

    • Validation of the Japanese Severe Respiratory Insufficiency Questionnaire in hypercapnic patients with noninvasive ventilation

      2017, Respiratory Investigation
      Citation Excerpt :

      Thus, even in patients with chronic airway obstruction, these tools may be inadequate for clinical assessment if chronic respiratory failure is also present. To address this issue, two questionnaires were developed and validated for HRQL assessment in patients with chronic respiratory failure: the Maugeri Respiratory Failure (MRF) Questionnaire [12] and the Severe Respiratory Insufficiency (SRI) Questionnaire [4,13]. The SRI Questionnaire was originally developed in German.

    View all citing articles on Scopus
    View full text